Meeting of the Advisory Committee on Training in Primary Care and Dentistry, 46548 [2019-19035]
Download as PDF
<![CDATA[
jbell on DSK3GLQ082PROD with NOTICES
46548
Federal Register / Vol. 84, No. 171 / Wednesday, September 4, 2019 / Notices
well as the risks of infection with
reprocessed duodenoscopes. Subject
matter of the panel meeting will include
potential methods and expert
assessment of how to reduce EtO
emissions to the environment from
medical device sterilization processes
without compromising assurance of
sterility or effective processing of
medical devices. The panel will also
discuss recommendations to reduce the
risk of infection from reprocessed
duodenoscopes.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its website prior to the
meeting, the background material will
be publicly available at the location of
the advisory committee meeting and the
background material will be posted on
FDA’s website after the meeting.
Background material will be available at
https://www.fda.gov/advisorycommittees/advisory-committeecalendar. Scroll down to the
appropriate advisory committee meeting
link.
FDA plans to provide a live webcast
of the November 6 and 7, 2019, meeting
of the General Hospital and Personal
Use Devices Panel of the Medical
Devices Advisory Committee. While
CDRH is working to make webcasts
available to the public for all advisory
committee meetings, there are instances
where the webcast transmission is not
successful; staff will work to re-establish
the transmission as soon as possible.
The link for the webcast is available at:
https://collaboration.fda.gov. Webcast
information, including the website
address for the webcast, are the
following, for their respective days:
November 6, 2019: https://
fda.yorkcast.com/webcast/Play/
eeed34f9b1f448f9a1f6ad05a4b
98d7d1d
November 7, 2019: https://
fda.yorkcast.com/webcast/Play/
49c5a76d5d1c422d8da028441ab
557de1d
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the Committee. Written
submissions may be made to the contact
person on or before October 22, 2019.
Oral presentations from the public will
be scheduled on November 6, 2019,
between approximately 1:30 p.m. and 2
p.m. and from 3:50 p.m. to 4:20 p.m.
and on November 7, 2019, between
approximately 1:20 p.m. and 1:50 p.m.
Those individuals interested in making
formal oral presentations should notify
the contact person and submit a brief
VerDate Sep<11>2014
19:08 Sep 03, 2019
Jkt 247001
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before October 16, 2019. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
October 17, 2019.
Persons attending FDA’s advisory
committee meetings are advised that
FDA is not responsible for providing
access to electrical outlets.
For press inquiries, please contact the
Office of Media Affairs at fdaoma@
fda.hhs.gov or 301–796–4540.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities .
If you require accommodations due to a
disability, please contact Artair Mallett,
at Artair.Mallett@fda.hhs.gov or 301–
796–9638 at least 7 days in advance of
the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/advisorycommittees/about-advisory-committees/
public-conduct-during-fda-advisorycommittee-meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: August 29, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–19079 Filed 9–3–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Service
Administration
Meeting of the Advisory Committee on
Training in Primary Care and Dentistry
Health Resources and Service
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Training in Primary Care
SUMMARY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 9990
and Dentistry (ACTPCMD) has
scheduled a public meeting. Information
about ACTPCMD and the agenda for this
meeting can be found on the ACTPCMD
website at: https://www.hrsa.gov/
advisory-committees/primarycaredentist/.
DATES: October 31, 2019, 10:00 a.m.–
5:00 p.m. Eastern Time.
ADDRESSES: This meeting will be held
by webinar.
• Webinar link: https://
hrsa.connectsolutions.com/ACTPCMD.
• Conference Call in number: (888)
455–0640; Passcode: HRSA COUNCIL
(voice response).
FOR FURTHER INFORMATION CONTACT:
Kennita Carter, MD, Senior Advisor and
Designated Federal Official, Division of
Medicine and Dentistry, HRSA, 5600
Fishers Lane, Rockville, Maryland
20857; phone (301) 945–3505; or email
BHWACTPCMD@hrsa.gov.
SUPPLEMENTARY INFORMATION:
ACTPCMD provides advice and
recommendations to the Secretary of
HHS (Secretary) on policy, program
development, and other matters of
significance concerning the activities
under section 747 of Title VII of the
Public Health Service (PHS) Act, as it
existed upon the enactment of Section
749 of the PHS Act in 1998.
At this meeting, ACTPCMD will
discuss matters concerning innovations
in training in primary care medicine
and dentistry as well as ACTPCMD’s
upcoming report and recommendations.
Agenda items are subject to change as
priorities dictate. Refer to the
ACTPCMD website for any updated
information concerning the meeting. An
agenda will be posted on the website at
least 14 calendar days before the
meeting. Members of the public will
have the opportunity to provide
comments. Public participants may
submit written statements in advance of
the scheduled meeting. Oral comments
will be honored in the order they are
requested and may be limited as time
allows. Requests to submit a written
statement or make oral comments to
ACTPCMD should be sent to Kennita
Carter using the contact information
above at least three business days prior
to the meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Kennita Carter at the address and
phone number listed above at least 10
business days before the meeting.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019–19035 Filed 9–3–19; 8:45 am]
BILLING CODE 4165–15–P
E:\FR\FM\04SEN1.SGM
04SEN1
]]>Agencies
[Federal Register Volume 84, Number 171 (Wednesday, September 4, 2019)]
[Notices]
[Page 46548]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19035]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Service Administration
Meeting of the Advisory Committee on Training in Primary Care and
Dentistry
AGENCY: Health Resources and Service Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Committee on Training in Primary
Care and Dentistry (ACTPCMD) has scheduled a public meeting.
Information about ACTPCMD and the agenda for this meeting can be found
on the ACTPCMD website at: https://www.hrsa.gov/advisory-committees/primarycare-dentist/.
DATES: October 31, 2019, 10:00 a.m.-5:00 p.m. Eastern Time.
ADDRESSES: This meeting will be held by webinar.
Webinar link: https://hrsa.connectsolutions.com/ACTPCMD.
Conference Call in number: (888) 455-0640; Passcode: HRSA
COUNCIL (voice response).
FOR FURTHER INFORMATION CONTACT: Kennita Carter, MD, Senior Advisor and
Designated Federal Official, Division of Medicine and Dentistry, HRSA,
5600 Fishers Lane, Rockville, Maryland 20857; phone (301) 945-3505; or
email [email protected].
SUPPLEMENTARY INFORMATION: ACTPCMD provides advice and recommendations
to the Secretary of HHS (Secretary) on policy, program development, and
other matters of significance concerning the activities under section
747 of Title VII of the Public Health Service (PHS) Act, as it existed
upon the enactment of Section 749 of the PHS Act in 1998.
At this meeting, ACTPCMD will discuss matters concerning
innovations in training in primary care medicine and dentistry as well
as ACTPCMD's upcoming report and recommendations. Agenda items are
subject to change as priorities dictate. Refer to the ACTPCMD website
for any updated information concerning the meeting. An agenda will be
posted on the website at least 14 calendar days before the meeting.
Members of the public will have the opportunity to provide comments.
Public participants may submit written statements in advance of the
scheduled meeting. Oral comments will be honored in the order they are
requested and may be limited as time allows. Requests to submit a
written statement or make oral comments to ACTPCMD should be sent to
Kennita Carter using the contact information above at least three
business days prior to the meeting.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Kennita Carter at the
address and phone number listed above at least 10 business days before
the meeting.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-19035 Filed 9-3-19; 8:45 am]
BILLING CODE 4165-15-P
